TIMETABLE

Mit­gliederver­samm­lung

Mit­gliederver­samm­lung

Mit­gliederver­samm­lung

Mit­gliederver­samm­lung

Glax­o­SmithK­line AG

Per­tus­sis vac­ci­na­tion dur­ing preg­nan­cy – pro­tect­ing the most vul­ner­a­ble

Sym­po­sium in Englisch

Speak­er:
Dr. phil. nat. Thier­ry Oliv­er Schaffner(a)
(a) Med­ical Lead Vac­cines, Med­ical Depart­ment, Glax­o­SmithK­line AG, Tal­strasse 3–5, 3053 München­buch­see, Switzer­land

Per­tus­sis (whop­ping cough) is one of the most impor­tant, bac­te­r­i­al vac­cine-pre­ventable infec­tious dis­eases in Switzer­land with 9’400 cas­es annu­al­ly (based on the Sen­tinel­la sur­veil­lance sys­tem 2012–2014)1.
The dis­ease rep­re­sents a high risk for chil­dren; par­tic­u­lar­ly for infants 6 months of age. Vac­ci­na­tion against per­tus­sis dur­ing preg­nan­cy is an effec­tive way to pro­tect the most vul­ner­a­ble group from the disease1.
With the lat­est update of the per­tus­sis vac­ci­na­tion rec­om­men­da­tions, the gynae­co­log­i­cal doctor‘s offices take an even more impor­tant role in pro­tect­ing moth­er and child from vac­cine-pre­ventable diseases2.
Many young patients do not have a gen­er­al prac­ti­tion­er; hence their gynae­col­o­gist is their con­tact per­son. For many gynae­col­o­gists vac­ci­na­tion of patients is not a day-to-day top­ic and there is a kind of inse­cu­ri­ty about the cur­rent vac­ci­na­tion rec­om­men­da­tions and the under­ly­ing sci­en­tif­ic ratio­nale includ­ing the ben­e­fit and safe­ty of vac­ci­na­tion of preg­nant women or women who plan preg­nan­cy. Fur­ther­more, the nation­al author­i­ties rec­om­mend cer­tain vac­ci­na­tions specif­i­cal­ly for health-care pro­fes­sion­als in order to max­i­mize pro­tec­tion of their patients2.
In this pre­sen­ta­tion we focus on the cur­rent rec­om­men­da­tions on per­tus­sis vac­ci­na­tion in preg­nant women pub­lished by the Swiss Fed­er­al Office of Pub­lic Health, the Fed­er­al Vac­ci­na­tion Com­mis­sion and the Swiss Asso­ci­a­tion for Gynae­col­o­gy and Obstetrics3. In this con­text we will show clin­i­cal data about the risk-ben­e­fit pro­file of this vac­ci­na­tion and we will give the audi­ence the oppor­tu­ni­ty to ask ques­tions.

Ref­er­ences: 1. Fed­er­al Office of Pub­lic Health (FOPH) and Fed­er­al Vac­ci­na­tion Com­mis­sion (FVC), Empfehlun­gen zur Präven­tion von Keuch­hus­ten, Guid­ances and Rec­om­men­da­tions, 2017; 2. Fed­er­al Office of Pub­lic Health (FOPH) and Fed­er­al Vac­ci­na­tion Com­mis­sion (FVC), Schweiz­erisch­er Impf­plan 2018, 2018; 3. Swiss Asso­ci­a­tion for Gynae­col­o­gy and Obstet­rics, Influen­za- und Per­tus­sis-Imp­fung in der Schwanger­schaft, Expert Opin­ion Let­ter No 55, Qual­i­ty Assur­ance Com­mis­sion, 2018

Experten:
Prof. Dr. med. Bruno Imthurn, Zürich/ Prof. Dr. med. Patrice Math­evet, Lausanne/ PD Dr. med. Dorothea Wun­der, Lau­sanne


P II/ 20
Improve­ment of out­come after adju­vant small field pelvic radi­a­tion in lymph node neg­a­tive high risk Stage IB cer­vi­cal can­cer patients – report of 20 year fol­low-up data
Präsentator/ ‑in: Kind André
Autoren: 1) Kind A.B., 1) Schoet­zau A., 2) Thomp­son S., 3) Bar­low E., 2) Jack­son M., 3) Hack­er N.F., 1) Heinzel­mann-Schwarz V.
Klinik: 1) Gyne­co­log­i­cal Can­cer Cen­tre, Uni­ver­si­ty Hos­pi­tal Basel, 2) Radi­a­tion Oncol­o­gy, Prince of Wales Clin­i­cal School, 3) Gyne­co­log­i­cal Can­cer Cen­tre, Roy­al Hos­pi­tal for Women, School of Women’s and Children’s Health/ 2,3 Uni­ver­si­ty of New South Wales, Syd­ney

P II/ 21
Inter­na­tion­al val­i­da­tion of ERAS® Soci­ety guide­lines on enhanced recov­ery for gyne­co­log­ic surgery
Präsentator/ ‑in: Pache Basile
Autoren: 1) Wijk L., 1) Udumyan R., 2) Pache B., 3) Alt­man A.D., 4) Williams L.L., 5) Elias K.M., 6) McGee J., 7) Wells T., 8) Hol­comb K.M., 2) Achtari C., 1) Ljungqvist O., 9) Dowdy S.C., 10) Nel­son G.
Klinik: 1) Öre­bro Uni­ver­si­ty Hos­pi­tal, Öre­bro, 2) Lau­sanne Uni­ver­si­ty Hos­pi­tal, 3) Win­nipeg Health Sci­ences Cen­tre, Win­nipeg, 4) Gyne­co­log­ic Oncol­o­gy of Mid­dle Ten­nessee, Nashville, 5) Brigham and Women’s Hos­pi­tal and Har­vard Med­ical School, Boston, 6) Lon­don Health Sci­ences Cen­tre, Lon­don, ON, 7) Roy­al Alexan­dra Hos­pi­tal, Edmon­ton, 8) Weill Cor­nell Med­ical Col­lege, New York, 9) Mayo Clin­ic, Rochester, 10) Tom Bak­er Can­cer Cen­tre, Cal­gary

P II/ 22
Mes­enchy­mal-to-epithe­lial tran­si­tion (MET) in ovar­i­an can­cer cells is trig­gered by gan­glio­side gly­co­syl­trans­ferase SIAT8
Präsentator/ ‑in: Cumin Cécile
Autoren: 1) Cumin C., 1,2) HuangY‑L., 1,2) Rim­mer N., 1,2) Liang C‑Y., 1,2) Nunez-Lopez M., 1,2) Fedi­er A., 1,3) Heinzel­mann-Schwarz V., 1,2) Jacob F.
Klinik: 1) Ovar­i­an Can­cer Research Pro­gram, Depart­ment of Bio­med­i­cine, 2) Gly­co-Oncol­o­gy, Ovar­i­an Can­cer Research, Bio­med­i­cine, 3) Hos­pi­tal for Women, Gyne­col­o­gy and Gyne­co­log­i­cal Oncology/ 1–3 Uni­ver­si­ty Hos­pi­tal Basel/ 1,3 Uni­ver­si­ty of Basel

P II/ 23
Clin­i­cal char­ac­ter­is­tics of patients with BRCA1/2‑mutated ovar­i­an can­cer
Präsentator/ ‑in: Nguyen Bich Doan
Autoren: Nguyen B.D., Samartzis E.P., Fink D., Dedes K.J.
Klinik: Gyne­col­o­gy and Gyneco-Oncol­o­gy, Uni­ver­si­ty Hos­pi­tal Zurich

P II/ 24
A Phase 4, dou­ble-blind, ran­dom­ized, place­bo-con­trolled, par­al­lel group, mul­ti-cen­tre study to eval­u­ate the effi­ca­cy, safe­ty, and tol­er­a­bil­i­ty of mirabegron in old­er adult patients with over­ac­tive blad­der syn­drome (PILLAR)
Präsentator/ ‑in: Von­der Müh­ll Car­o­line
Autoren: 1) Wagg A., 2) Staskin D., 3) Engel E., 4) Her­schorn S., 5) Kristy RM., 5) Scher­mer CR.
Klinik: 1) Uni­ver­si­ty of Alber­ta, Geri­atric Med­i­cine, Edmon­ton, 2) St Elizabeth’s Med­ical Cen­ter, Divi­sion of Urol­o­gy, Boston, 3) Bayview Research Group, Val­ley Vil­lage, 4) Uni­ver­si­ty of Toron­to, Sun­ny­brook Health Sci­ences Cen­tre, Toron­to, 5) Astel­las Phar­ma Glob­al Devel­op­ment, Inc., North­brook

P II/ 25
Accu­ra­cy of sono-mor­pho­log­i­cal cri­te­ria and the expe­ri­ence-depen­dent inter-observ­er vari­abil­i­ty in axil­lary lymph node assesse­ment
Präsentator/ ‑in: Cam­pono­vo Car­oli­na
Autoren: Cam­pono­vo C., Knabben L., Siegen­thaler F., Mueller M.D.
Klinik: SGS/SKL & DKG cer­ti­fied Breast Can­cer Cen­ter, Obstet­rics and Gyne­col­o­gy, lnsel­spi­tal, Bern Uni­ver­si­ty Hos­pi­tal, Uni­ver­si­ty of Bern

P II/ 26
Cor­re­la­tion of extent of resid­ual micro­cal­ci­fi­ca­tions and intra-oper­a­tive find­ings after stereo­tac­tic vac­u­um-assist­ed breast biop­sy in DCIS
Präsentator/ ‑in: Krisch­er Bene­dict
Autoren: 1) Krisch­er B., 3) Forte S., 2) Singer G., 3) Kubik R., 1) Leo C.
Klinik: 1) Gyne­col­o­gy, Breast Cen­ter, 2) Pathol­o­gy, 3) Radiology/ 1–3 Can­ton­al Hos­pi­tal Baden

P II/ 27
Laser ther­a­py for female stress uri­nary incon­ti­nence: a new treat­ment alter­na­tive to slings?
Präsentator/ ‑in: Gam­per Mar­i­anne
Autoren: 1) Gam­per M., 2) Kusz­ka A., 2) Kociszews­ki J., 1) Walser C., 1) Viereck V.
Klinik: 1) Gyne­col­o­gy and Obstet­rics, Can­ton­al Hos­pi­tal Frauen­feld, 2) Gyne­col­o­gy and Obstet­rics, Luther­an Hos­pi­tal Hagen-Haspe

P II/ 28
Uter­ine Fibroid Ther­a­py with­out Knives or Hor­mones. Prospec­tive Data Analy­sis: Effi­cien­cy of Uter­ine Fibroid abla­tion with Radiofre­quen­cy Ener­gy in reduc­ing Uter­ine Fibroid vol­ume at 3 and 12 month
Präsentator/ ‑in: Jar­rah Omar
Autoren: Jar­rah O., Sojko­va M., Christof­fel L.
Klinik: Obstet­rics and Gyne­col­o­gy, Hos­pi­tal Oberen­gadin, Samedan

Vor­standssitzung

Mit­gliederver­samm­lung

Intu­itive Sur­gi­cal Sàrl

The place of da Vin­ci robot­ic assist­ed surgery in a GYN pro­gram

Sym­po­sium in Englisch

Ref­er­ent:
Prof. Heub­n­er, Kan­ton­sspi­tal Baden

Experten:
Prof. Dr. med. Daniel Fink, Zürich/ Prof. Dr. med. Ossi R. Köch­li, Zürich/ Prof. Dr. med. Patrick Petig­nat, Genf/ Dr. med. Nico­las Vul­liemoz, Lau­sanne


P III/ 30
Man­age­ment of preg­nan­cies of unknown loca­tion: is it time to adopt new pro­to­cols?
Präsentator/ ‑in: Francey Isaline
Autoren: Francey I., Math­evet P., Jacot-Guil­lar­mod M., Rieder W.
Klinik: Gyne­col­o­gy, Uni­ver­si­ty Hos­pi­tal Lau­sanne

P III/ 31
Impact of nerve-spar­ing laparo­scop­ic sacro­colpopexy on post­op­er­a­tive defe­ca­tion
Präsentator/ ‑in: Greten­er Fabi­enne
Autoren: Greten­er F., Schär G., Held­stab S., Sar­los D.
Klinik: Gyne­col­o­gy and Gyneco-Oncol­o­gy, Can­ton­al Hos­pi­tal Aarau

P III/ 32
Seg­men­ta­tion and 3D-Recon­struc­tion of the female pelvis using 3D-Slicer and the dig­i­tal dataset of the Vis­i­ble Human Project
Präsentator/ ‑in: Singer Adri­an
Autoren: 1) Singer A., 2) Win­klehn­er T., 1) Fink D., 1) Betschart C.
Klinik: 1) Gyne­col­o­gy, Uni­ver­si­ty Hos­pi­tal Zurich, 2) ARTORG Cen­ter for Bio­med­ical Engi­neer­ing Research

P III/ 33
«Eco­log­ic and hor­mone-free» or mestru­a­tion­al cup and dis­lo­ca­tion of cop­per-IUD
Präsentator/ ‑in: Los­er Melanie
Autoren: Los­er M., Brand­ner S., Stämpfli A.
Klinik: Frauen­z­im­mer Bern AG

P III/ 34
Val­i­da­tion study of CLASSIC — Clas­si­fi­ca­tion of Intra­op­er­a­tive Com­pli­ca­tions — appli­ca­tion in oper­a­tive gyne­col­o­gy
Präsentator/ ‑in: Nuss­baumer Jari
Autoren: 1) Nuss­baumer J., 2,3,4) Dell-Kuster S., 2) Nuno G., 1) Heinzel­mann-Schwarz V., 1) Kind A.B.
Klinik: 1) Gyne­col­o­gy and Gyn. Oncol­o­gy, 2) Anes­the­si­ol­o­gy, 3) Insti­tute for Clin­i­cal Epi­demi­ol­o­gy and Bio­sta­tis­tics, 4) Clin­i­cal Research/ 1,2 Uni­ver­si­ty Hos­pi­tal Basel, 3,4 Uni­ver­si­ty of Basel

P III/ 35
Chlamy­dia tra­choma­tis: is per­sis­tance linked to a lack of knowl­edge ?
Präsentator/ ‑in: Grouz­mann Estelle
Autoren: Grouz­mann E., Faouzi M., Math­evet P., Jacot-Guil­lar­mod M.
Klinik: Gyne­col­o­gy, Uni­ver­si­ty Hos­pi­tal Lau­sanne

P III/ 36
Sen­tinel lymph node map­ping in vul­var can­cer – A new approach with indo­cya­nine green and near infrared flu­o­res­cence imag­ing
Präsentator/ ‑in: Fabi­an Sarah
Autoren: Fabi­an S., Siegen­thaler F., Imbo­den S., Papa­dia A., Mueller M.D.
Klinik: Obstet­rics and Gyne­col­o­gy, Insel­spi­tal, Bern Uni­ver­si­ty Hos­pi­tal, Uni­ver­si­tiy of Bern

P III/ 37
The nat­ur­al his­to­ry of endometrio­sis recur­rence: a long-term lon­gi­tu­di­nal study
Präsentator/ ‑in: Ma Lijuan
Autoren: 1) Nir­gianakis K., 1,2) Ma LJ., 1,2) Andrieu T., 1) Mueller M.D.
Klinik: 1) Obstet­rics and Gyne­col­o­gy, Insel­spi­tal, Bern Uni­ver­si­ty Hos­pi­tal, 2) Bio­Med­ical Research, Uni­ver­si­ty of Bern

P III/ 38
3D Laparoscopy- does it make us bet­ter?
Präsentator/ ‑in: Bobore­lu Alexan­dra-Cristi­na
Autoren: Bobore­lu A.-C., Kanel­los P., Müller A.
Klinik: Gyne­col­o­gy and Obstet­rics, Kan­ton­sspi­tal Uri

Vor­standssitzung

Mit­gliederver­samm­lung

Mit­gliederver­samm­lung

Mit­gliederver­samm­lung

Mit­gliederver­samm­lung